ANALYSIS OF TICAGRELOR AND PRASUGREL CORRELATION WITH CYP2C19 GENETIC VARIANTS AS ALTERNATIVE DRUGS FOR CLOPIDOGREL

被引：0
|
作者：
Seo, B. [1 ]
Lee, S. [1 ]
Lee, I. [1 ]
Kim, S. [1 ]
Chiang, J. [1 ]
机构：
[1] Cipherome, San Jose, CA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-022
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 50 条
  • [1] Prasugrel and Clopidogrel in Chinese CYP2C19 Allelic Variants following Maintenance Doses.
    Kirkwood, Sandra
    McCorkle, Kathy
    Walker, Joseph
    Small, David
    Farid, Nagy
    Loh, Mei Teng
    Ho, Mary
    Ong, Guan Koon
    Shen, Lei
    Jakubowski, Joseph
    Kelly, Ronan
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (9A): : 105B - 105B
  • [2] CYP2C19 Genetic Variants and Clinical Outcomes With Clopidogrel: A Collaborative Meta-Analysis
    Mega, Jessica L.
    Simon, Tabassome
    Anderson, Jeffrey L.
    Bliden, Kevin
    Collet, Jean-Phillippe
    Danchin, Nicolas
    Giusti, Betti
    Gurbel, Paul
    Horne, Benjamin D.
    Kastrati, Adnan
    Montalescot, Gilles
    Neumann, Franz-Josef
    Shen, Lei
    Sibbing, Dirk
    Steg, P. Gabriel
    Trenk, Dietmar
    Wiviott, Stephen D.
    Sabatine, Marc S.
    CIRCULATION, 2009, 120 (18) : S598 - S599
  • [3] Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants
    Kelly, Ronan P.
    Close, Sandra L.
    Farid, Nagy A.
    Winters, Kenneth J.
    Shen, Lei
    Natanegara, Fanni
    Jakubowski, Joseph A.
    Ho, Mary
    Walker, Joseph R.
    Small, David S.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (01) : 93 - 105
  • [4] Effect of CYP2C19*2 and*17 Genetic Variants on Platelet Response to Clopidogrel and Prasugrel Maintenance Dose and Relation to Bleeding Complications
    Grosdidier, Charlotte
    Quilici, Jacques
    Loosveld, Marie
    Camoin, Laurence
    Moro, Pierre Julien
    Saut, Noemie
    Gaborit, Benedicte
    Pankert, Mathieu
    Cohen, William
    Lambert, Marc
    Beguin, Shirley
    Morange, Pierre Emmanuel
    Bonnet, Jean-Louis
    Alessi, Marie-Christine
    Cuisset, Thomas
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (07): : 985 - 990
  • [5] The cost-effectiveness of genetic testing for CYP2C19 variants to guide antiplatelet therapy with clopidogrel or prasugrel in R. Macedonia
    Nestorovska, A. Kapedanovska
    Naumovska, Z.
    Sterjev, Z.
    Grozdanova, A.
    Dimovski, A.
    Shuturkova, L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 567 - 567
  • [6] Prasugrel or clopidogrel in non-ST-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention
    Kim, S. J.
    Kim, M. H.
    Jin, C. D.
    Shin, E. S.
    Ann, S. H.
    Cho, Y. R.
    Park, J. S.
    Park, T. H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1213 - 1214
  • [7] Effect of PON1 and CYP2C19 genetic variants on the pharmacokinetics and pharmacodynamics of clopidogrel
    Hulot, J-S.
    Collet, J-P.
    Cayla, G.
    Sylvain, J.
    Finzi, J.
    Allanic, F.
    Bellemain-Appaix, A.
    Anzaha, G.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2011, 32 : 341 - 342
  • [8] Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype A POPular Genetics Subanalysis
    Claassens, Daniel M. F.
    Bergmeijer, Thomas O.
    Vos, Gerrit J. A.
    Hermanides, Renicus S.
    't Hof, Arnoud W. J. van
    van der Harst, Pim
    Barbato, Emanuele
    Morisco, Carmine
    Gin, Richard M. Tjon Joe
    Asselbergs, Folkert W.
    Mosterd, Arend
    Herrman, Jean-Paul R.
    Dewilde, Willem J. M.
    Janssen, Paul W. A.
    Kelder, Johannes C.
    Mahmoodi, Bakhtawar K.
    Deneer, Vera H. M.
    ten Berg, Jurrien M.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (04) : 402 - 411
  • [9] Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis
    Mega, Jessica L.
    Close, Sandra L.
    Wiviott, Stephen D.
    Shen, Lei
    Walker, Joseph R.
    Simon, Tabassome
    Antman, Elliott M.
    Braunwald, Eugene
    Sabatine, Marc S.
    LANCET, 2010, 376 (9749): : 1312 - 1319
  • [10] Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
    Brandt, J. T.
    Close, S. L.
    Iturria, S. J.
    Payne, C. D.
    Farid, N. A.
    Ernest, C. S., II
    Lachno, D. R.
    Salazar, D.
    Winters, K. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (12) : 2429 - 2436
12345